This week, Brent Nally talks about how UT Health San Antonio is getting two million dollars in funding to study rapamycin in Alzheimer’s, stem cells producing cartilage in osteoarthitic joints, gene therapy for motor function in aged mice, the link between immunosenescence and aging, and the use of senolytics for transplantation of aged organs.
Further Reading
UT Health San Antonio and Alzheimer’s
Write a comment: